Medicus Sciences Acquisition Corp. Warrant
MSACW
MSACW was delisted on the 17th of February, 2023.
17 hedge funds and large institutions have $366K invested in Medicus Sciences Acquisition Corp. Warrant in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
6% more funds holding
Funds holding: 16 → 17 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
18% less capital invested
Capital invested by funds: $444K → $366K (-$78K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$17.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$28 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DMKJ
1
David M. Knott Jr
| $256K | – | – | – |
|
2
Adage Capital Partners
Boston,
Massachusetts
| $20K | – | – | – |
|
|
HM
3
HealthCor Management
New York
| $15K | – | – | – |
|
|
KC
4
Kepos Capital
New York
| $11K | – | – | – |
|
|
MC
5
Meteora Capital
Boca Raton,
Florida
| $11K | +$17.5K | +62,038 | New |
|
|
APM
6
Avidity Partners Management
Dallas,
Texas
| $10K | – | – | – |
|
|
SCM
7
Silverarc Capital Management
Boston,
Massachusetts
| $9K | – | – | – |
|
|
AAA
8
Affinity Asset Advisors
New York
| $8K | – | – | – |
|
|
KCM
9
Kingdon Capital Management
New York
| $6K | – | – | – |
|
|
RI
10
RTW Investments
New York
| $6K | – | – | – |
|
|
WCMNY
11
Westchester Capital Management (New York)
Valhalla,
New York
| $4K | – | – | – |
|
|
AC
12
Ayrton Capital
Westport,
Connecticut
| $3K | – | – | – |
|
|
PC
13
Periscope Capital
Toronto,
Ontario, Canada
| $3K | – | – | – |
|
|
CCA
14
Cruiser Capital Advisors
Stamford,
Connecticut
| $2K | – | – | – |
|
|
JAM
15
JW Asset Management
Miami Beach,
Florida
| $2K | – | – | – |
|
|
16
UBS Group
Zurich,
Switzerland
| – | -$28 | -100 | -4% |
|
MSACW Hedge Fund Activity: Q2 2022 in Review
17 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Medicus Sciences Acquisition Corp. Warrant (MSACW) for Q2 2022, worth a combined $366K — down 18% from $444K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new MSACW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Meteora Capital, opening a new position worth an estimated $17.5K. The largest seller was UBS Group, cutting an estimated $28.
- 17 institutional investors held Medicus Sciences Acquisition Corp. Warrant (MSACW) as of Q2 2022, up from 16 in Q1 2022.
- Funds reported $366K of Medicus Sciences Acquisition Corp. Warrant stock for Q2 2022, down 18% quarter-over-quarter.
- 1 fund opened new Medicus Sciences Acquisition Corp. Warrant positions in Q2 2022 and 0 closed out, a net change of +1 holder.
- The largest Medicus Sciences Acquisition Corp. Warrant buyer in Q2 2022 was Meteora Capital, an estimated $17.5K added.
- The largest Medicus Sciences Acquisition Corp. Warrant seller in Q2 2022 was UBS Group, an estimated $28 sold.
Based on aggregated 13F filings for Q2 2022.